FDA, EU Novel Food, NMPA: Regulatory Hurdles for Japanese Ingredients

Why this matters early

Many Japanese ingredients that are entirely uncontroversial in domestic Japanese markets — kombu varieties, specific fermented preparations, certain functional extracts, novel cultivar derivatives — sit on the boundary or outside the approved-ingredient lists in major export markets. The regulatory gating mechanisms are very different in scope, timeline, and cost. Surface this early in your sourcing project to avoid a Q4 surprise.

United States: FDA framework for food and supplements

Food ingredients in the US can enter market through several pathways depending on history of use:

• GRAS (Generally Recognized As Safe) — most traditional Japanese foods (miso, soy sauce, matcha, mochi, seaweed varieties widely sold pre-2000) are GRAS by long history of use. Producers can self-affirm GRAS or seek FDA GRAS Notification.
• Food additive petition — required for novel food additives without GRAS history. Multi-year process; cost $100k+.
• Dietary Supplement Health and Education Act (DSHEA) — supplement positioning for ingredients with new dietary ingredient (NDI) notification if first marketed after 1994.
• Cosmetic — MoCRA (2024) — Modernization of Cosmetics Regulation Act. Facility registration + product listing required for cosmetics shipped to US.

European Union: Novel Food regulation

EU Regulation (EU) 2015/2283 (Novel Food regulation) governs any food not significantly consumed in the EU before May 1997. For Japanese ingredients, the practical implications:

• Pre-1997 EU consumption history exempt — soy sauce, miso, matcha, sake, common Japanese teas, common seaweed (kombu, wakame, nori) — these are not novel and don't need authorisation. Sale records pre-1997 in EU member states are evidence.
• Post-1997 ingredients require authorisation — fucoidan-rich extracts, specific functional fermented preparations, novel cultivars or extraction methods may require Novel Food authorisation. Process: scientific dossier + EFSA evaluation + Commission decision. Timeline: typically 18–24 months. Cost: €50k–€500k+.
• Traditional food from third country (TFTC) pathway — shorter route for ingredients with documented 25+ year safe use in non-EU country. Faster (~12 months) and cheaper than full Novel Food authorisation.
• Cosmetic — Regulation (EC) 1223/2009 — INCI listing required; CosIng database lists permitted/prohibited substances. Some Japanese cosmetic ingredients require additional safety dossier.

China: NMPA and GACC frameworks

China splits regulatory responsibility:

• General Administration of Customs (GACC) — producer facility registration mandatory for all food shipped to China. Producer applies via local AMR; takes 2–6 months for first registration.
• National Medical Products Administration (NMPA) — cosmetic ingredient registration. New cosmetic ingredients (not in IECIC list) require notification or registration depending on risk class. Process: 4–12 months for NCI notification; 1–3 years for higher-risk ingredients.
• Food safety standards — GB 2762 (contaminants), GB 2763 (pesticide MRLs), GB 2718 (fermented condiments), category-specific GB standards. Often stricter than Japanese positive list; verify per ingredient.
• Cross-border e-commerce (CBEC) pathway — products sold via approved CBEC platforms (Tmall Global, JD Worldwide, etc.) face simpler requirements; useful for testing China market without full NMPA registration.

Step-by-step: how to determine which regulatory pathway your Japanese ingredient needs

A 6-step decision tree before you commit budget to a Japanese ingredient. Run through this with your regulatory consultant before sample work begins:

1. 1

   Identify the ingredient's destination market and product category

   Same ingredient lands on different regulatory shelves: kombu in food vs supplement vs cosmetic faces different rules in each market. Pin down the destination + category before searching pathways.

2. 2

   Check pre-market history in the destination

   US: search FDA GRAS Notice Inventory for the ingredient. EU: search the Union list of authorised novel foods + check pre-1997 consumption evidence. China: search IECIC (cosmetic) / GACC list (food) for existing entries. If the ingredient appears with your intended use, no new pathway is needed.

3. 3

   If absent from the destination's lists, classify the gap

   US: missing GRAS → self-affirm (cheap, fast) or FDA GRAS Notification (slower, public confidence). EU: post-1997 first marketing → Novel Food authorisation (18–24 months) or TFTC (12 months if 25+ years safe use abroad). China: cosmetic not in IECIC → NCI notification or registration based on risk class.

4. 4

   Estimate timeline and cost before committing

   Use the table below as a starting point but get a regulatory consultant quote — costs vary widely by complexity. Factor regulatory timeline into your retail launch plan: an EU Novel Food path can push launch by 2 years.

5. 5

   Decide go / no-go / alternative

   If the regulatory cost exceeds the projected first-year margin, consider: (a) substituting a related ingredient with cleaner regulatory status, (b) switching destination market, (c) using a fast-lane channel (US DSHEA supplement positioning, China CBEC, EU TFTC pathway).

6. 6

   Coordinate the producer's role from day one

   Producer must supply: detailed manufacturing process, full specification, safety / toxicology data, history-of-use evidence with dates and volumes. Most Japanese SMEs have not assembled these for export — budget 4–8 weeks of producer time. Build this into the sample agreement.

Realistic timelines and costs